Stock Events

Stock Events

Denali Therapeutics (DNLI) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.8

-0.73

-0.66

-0.59

Details

Expected EPS

-0.798795

Actual EPS

-0.67

Surprise EPS

0.13

Surprise Percent

+16.12%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.67 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.